Target Name: MCMBP
NCBI ID: G79892
Review Report on MCMBP Target / Biomarker Content of Review Report on MCMBP Target / Biomarker
MCMBP
Other Name(s): FLJ36756 | FLJ13081 | MCM-binding protein | Minichromosome maintenance complex-binding protein | MCMBP variant 1 | Mini-chromosome maintenance complex-binding protein | minichromosome maintenance complex binding protein | MCMBP_HUMAN | Mini-chromosome maintenance complex-binding protein (isoform 1) | C10orf119 | Minichromosome maintenance complex binding protein | Minichromosome maintenance complex binding protein, transcript variant 1 | MCM-BP

MCMBP: A Protein of Interest for Drug Targeting and Biomarker

MCMBP, or menin-M1-like protein 36756, is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of microtubules, which are essential for cell division and transport of organelles within cells. MCMBP has also been shown to play a role in the development and progression of various diseases, including cancer.

One of the most promising aspects of MCMBP is its potential as a drug target. MCMBP has been shown to be involved in a variety of cellular processes that are relevant to many diseases, including cancer, neurodegenerative diseases, and developmental disorders. Its involvement in these processes has led to the development of a number of potential therapeutic strategies.

One approach to targeting MCMBP is to use small molecules that can modulate its activity. This can be done by binding to MCMBP and interacting with its active site, which is the region of the protein that is responsible for its function. There is a growing body of research on the use of small molecules to modulate MCMBP activity, with a focus on developing drugs that can be used to treat a variety of diseases.

Another approach to targeting MCMBP is to use antibodies that can specifically recognize and label MCMBP. This can be done by using antibodies that are designed to recognize MCMBP on its cell surface, and then using these antibodies to label MCMBP in the cells. This can be a powerful tool for studying the behavior of MCMBP in live cells and can help to identify new targets for drug development.

MCMBP has also been shown to be involved in a number of diseases, including cancer. In many cases, MCMBP is involved in the regulation of cell division and the development of cancer, and drugs that can modulate its activity may be effective in treating these diseases. For example, studies have shown that inhibiting MCMBP activity can be an effective way to inhibit the growth of cancer cells and reduce the risk of cancer progression.

In addition to its potential as a drug target, MCMBP is also of interest as a biomarker. Its expression has been shown to be associated with a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. This makes it a potential source of diagnostic information, as well as a target for therapeutic intervention.

Overall, MCMBP is a protein that is of great interest to researchers due to its role in a variety of cellular processes and its involvement in the development and progression of many diseases. Its potential as a drug target and biomarker make it an attractive target for further study, and its properties make it an important player in the field of cellular biology.

Protein Name: Minichromosome Maintenance Complex Binding Protein

Functions: Associated component of the MCM complex that acts as a regulator of DNA replication. Binds to the MCM complex during late S phase and promotes the disassembly of the MCM complex from chromatin, thereby acting as a key regulator of pre-replication complex (pre-RC) unloading from replicated DNA. Can dissociate the MCM complex without addition of ATP; probably acts by destabilizing interactions of each individual subunits of the MCM complex. Required for sister chromatid cohesion

The "MCMBP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MCMBP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MCMDC2 | MCOLN1 | MCOLN2 | MCOLN3 | MCPH1 | MCPH1-AS1 | MCPH1-DT | MCRIP1 | MCRIP2 | MCRS1 | MCTP1 | MCTP2 | MCTS1 | MCTS2 | MCU | MCUB | MCUR1 | MDC1 | MDFI | MDFIC | MDGA1 | MDGA2 | MDH1 | MDH1B | MDH2 | MDK | MDM1 | MDM2 | MDM4 | MDN1 | MDS2 | ME1 | ME2 | ME3 | MEA1 | MEAF6 | MEAF6P1 | MEAK7 | Mechanoelectrical transducer (MET) channel | Mechanosensitive Ion Channel | MECOM | MECOM-AS1 | MeCP1 histone deacetylase (HDAC) complex | MECP2 | MECR | MED1 | MED10 | MED11 | MED12 | MED12L | MED13 | MED13L | MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9 | MEDAG | Mediator Complex | Mediator of RNA Polymerase II Transcription | MEF2A | MEF2B | MEF2C | MEF2C-AS1 | MEF2C-AS2 | MEF2D | MEFV | MEG3 | MEG8 | MEG9 | MEGF10 | MEGF11 | MEGF6 | MEGF8 | MEGF9 | MEI1 | MEI4 | MEIG1 | MEIKIN